Protein Sciences will pitch Flublok to Connecticut home healthcare association; New biotech formed to develop cancer vaccines;

> Protein Sciences is partnering with the Connecticut Association for Healthcare at Home, which will enable it to sell its Flublok vaccine to member home-health and hospice agencies. News

> The Fight Against Cancer Innovation Trust and its partners formed Turnstone Biologics, a new biotech to develop cancer vaccines. Release

> A study published in Pediatrics showed that effectiveness of the Tdap vaccine for pertussis "decreases substantially" in adolescents after two to four years. News

> Gavi will continue to provide financial support for vaccinations and immunization programs in India, but only until 2020. Story

And Finally... The Chittoor District Medical and Health Department in India is scheduled to launch a pentavalent vaccine Thursday, but misspelled it as "pentaviolent" in a press release. An official went on to explain that the vaccine works "violently" against diseases. While a senior official later admitted the mistake, some continue to call it "violent." Story

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.

Takeda has spent considerable resources on its phase 3 dengue vaccine, and now data show the shot was 80% effective in preventing dengue.